MedTrace Logo

Treatment of Neck and Upper Limb Pain Using BurstDR (De Ridder) Stimulation

NCT03159169 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2024-09-23

No results posted yet for this study

Summary

This is a prospective, open label, multicenter feasibility study to evaluate the safety and therapeutic efficacy of BurstDRTM SCS in treating chronic neck pain with or without radiation down to arm/shoulder/upper back

Conditions

  • Neck Pain
  • Upper Limb Pain

Interventions

DEVICE

Spinal Cord Stimulation (SCS)

Implantation of SCS electrodes and stimulator according to clinical standards

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Adnan Al-Kaisy, MD · Guy's St. Thomas

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2022-04-30
Completion
2022-08-31
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03159169 on ClinicalTrials.gov